CV Lattes
ORCID
Abstract
Antineoplastic drug development is based on the discovery of efficient molecules with lower cost and specific for the neoplastic cell target. In recent years, hybrid molecules' conceit has gained prominence, as they act synergistically, in reduced doses, and less likely to develop resistance, compared to the individual antineoplastic compounds. The screening of a new molecule can be perf…